Randomised, sham-placebo, parallel study of Nasal Continuous Positive Airway Pressure (NCPAP) for the treatment of Obstructive Sleep Apnoea (OSA)
Doubt has been expressed as to the true symtomatic benefit derived from NCPAP in patients with OSA. We are carrying out a randomised, sham placebo-controlled trial. Patients are recruited who have more than 10/hr >4%SaO2 dips, and Epworth sleepiness scores (ESS) of more than 9. Initial assess...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1998
|